Hidenori Funamizu

Title: Hidenori Funamizu: Innovator in Pharmaceutical Chemistry

Introduction

Hidenori Funamizu is a notable inventor based in Kyoto, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of compounds that promote growth hormone release.

Latest Patents

Funamizu holds 3 patents that focus on innovative compounds. His latest patents include amide derivatives, which are compounds of structural Formula (I) where A is a lipophilic group including an aliphatic bridging group, B is a lipophilic group, D is a group having at least one amino or substituted amino group, and R is hydrogen, alkyl, or cycloalkyl. These compounds, along with their pharmaceutically acceptable salts and individual isomers, exhibit growth hormone releasing activity in humans or animals. Another significant patent involves N-acylated lipophilic amino acid derivatives, which share a similar structural formula and functionality.

Career Highlights

Throughout his career, Funamizu has worked with prominent organizations such as Kaken Pharmaceutical Company, Ltd. and Molecular Research Institute. His work in these companies has allowed him to advance his research and contribute to the pharmaceutical industry.

Collaborations

Funamizu has collaborated with esteemed colleagues, including Nobuo Ishiyama and Satoru Ikegami. These partnerships have further enriched his research endeavors and innovations.

Conclusion

Hidenori Funamizu is a distinguished inventor whose work in pharmaceutical chemistry has led to valuable advancements in growth hormone releasing compounds. His contributions continue to impact the field positively.